Skip to content

Clinical trials

Observational Diabetes Mellitus trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Observational Clear all

2,021 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200122
200210
200326
200431
200539
200651
200782
200893
200999
201085
201179
201293
201375
201484
201567
201669
201792
201879
201978
202099
202194
2022103
202391
202494
2025104
202679

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,188
Unknown status358
Recruiting179
Not yet recruiting85
Active, not recruiting66
Terminated47
Withdrawn47
Enrolling by invitation43
Suspended8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S148
National Heart, Lung, and Blood Institute (NHLBI)43
AstraZeneca30
Assiut University25
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)23
Abbott Diabetes Care20
National Taiwan University Hospital18
Brigham and Women's Hospital17
DexCom, Inc.16
University of Toronto14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus2,021
Diabetes Mellitus, Type 2384
Hypertension231
Obesity215
Cardiovascular Diseases205
Diabetes Mellitus, Type 1173
Insulin Resistance93
Heart Diseases88
Metabolic Syndrome78
Coronary Artery Disease75

Trials

Showing 26 to 50 of 2,021. Each trial links to its page on Pharma Observatory.

1,921 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.